ResearchMoz

GenericsWeb Market Research Reports

GenericsWeb provides patent intelligence to the world’s leading pharmaceutical companies, allowing their customers to significantly reduce the risk of developing patent-infringing pharmaceuticals for global markets, and identify when and where they can launch products. With headquarters in Sydney, and customer support offices in North America and Europe, GenericsWeb boasts 50% of the world’s top 10 generics companies as key customers, including global heavyweights such as Pfizer, Novartis/Sandoz, Hospira, Mylan, Sanofi-Aventis, Dr Reddy’s, Amgen and Baxter

List of reports from GenericsWeb

Displaying 251 to 280 (of 721 records)
Pages: « Prev  4 5 6 7 8 9 10 11 12 13   Next »
Ondansetron - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ondansetron Ondansetron indications: Emesis;...
$1200
Orlistat - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Orlistat Orlistat indications: Adjunct in...
$1200
Oxaliplatin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Oxaliplatin Oxaliplatin indications:...
$1200
Paclitaxel - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Paclitaxel Paclitaxel indications: Ovarian,...
$1200
Pantoprazole - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Pantoprazole Pantoprazole indications:...
$1200
Pegfilgrastim - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Pegfilgrastim Pegfilgrastim indications:...
$1200
Penciclovir - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Penciclovir Penciclovir indications:...
$1200
Pergolide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Pergolide Pergolide indications: Parkinson's...
$1200
Perindopril - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Perindopril Perindopril indications:...
$1200
Pioglitazone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Pioglitazone Pioglitazone indications: Diabetes...
$1200
Pramipexole - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Pramipexole Pramipexole indications:...
$1200
Pravastatin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Pravastatin Pravastatin indications:...
$1200
Pregabalin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Pregabalin Pregabalin indications: Neuropathic...
$1200
Quetiapine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Quetiapine Quetiapine indications:...
$1200
Quinapril - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Quinapril Quinapril indications: Hypertension,...
$1200
Rabeprazole - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Rabeprazole Rabeprazole indications: Peptic...
$1200
Raloxifene - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Raloxifene Raloxifene indications:...
$1200
Ramipril - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ramipril Ramipril indications: Hypertension;...
$1200
Ranolazine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ranolazine Ranolazine indications: Treatment of...
$1200
Repaglinide - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Repaglinide Repaglinide indications: Diabetes...
$1200
Riluzole - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Riluzole Riluzole indications: Amyotrophic...
$1200
Risedronic Acid - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Risedronic Acid Risedronic Acid indications:...
$1200
Risperidone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Risperidone Risperidone indications:...
$1200
Rivastigmine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Rivastigmine Rivastigmine indications:...
$1200
Ropinirole - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ropinirole Ropinirole indications: Parkinson's...
$1200
Ropivacaine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ropivacaine Ropivacaine indications: Surgical...
$1200
Rosiglitazone - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Rosiglitazone Rosiglitazone indications: Type...
$1200
Rotigotine - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Rotigotine Rotigotine indications: Treatment...
$1200
Roxithromycin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Roxithromycin Roxithromycin indications: Soft...
$1200
Selegiline - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Dec 2011  
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Selegiline Selegiline indications: Treatment...
$1200
 
Displaying 251 to 280 (of 721 records)
Pages: « Prev  4 5 6 7 8 9 10 11 12 13   Next »